Giulia Biffi, Ph.D.
Affiliations: | 2010-2014 | University of Cambridge, Cambridge, England, United Kingdom |
Area:
PDACWebsite:
http://tuvesonlab.labsites.cshl.edu/giulia-biffi/Google:
"Giulia Biffi"Parents
Sign in to add mentor| Shankar Balasubramanian | grad student | 2010-2014 | Cambridge |
| David A. Tuveson | post-doc | 2014- | CSHL |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lloyd EG, Jihad M, Manansala JS, et al. (2025) SMAD4 and KRAS Status Shape Cancer Cell-Stromal Crosstalk and Therapeutic Response in Pancreatic Cancer. Cancer Research |
| Cheng PSW, Zaccaria M, Biffi G. (2024) Functional heterogeneity of fibroblasts in primary tumors and metastases. Trends in Cancer |
| Veghini L, Pasini D, Fang R, et al. (2024) Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer. Nature Communications. 15: 10534 |
| Mucciolo G, Li W, Biffi G. (2024) Cancer-Associated Fibroblasts: From Spectators to Protagonists in Pancreatic Cancer Progression. Cancer Research. 84: 2938-2940 |
| Bermejo-Rodriguez C, Araos Henríquez J, Caligiuri G, et al. (2024) Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. Cancer Research |
| Araos Henríquez J, Biffi G. (2022) Tracing back to one of the origins of immune evasion in pancreatic cancer. Cancer Cell. 40: 595-597 |
| Steele NG, Biffi G, Kemp SB, et al. (2021) Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Lau AN, Li Z, Danai LV, et al. (2020) Dissecting cell type-specific metabolism in pancreatic ductal adenocarcinoma. Elife. 9 |
| Biffi G. (2020) Tracing the Origin of Fibroblasts in Pancreatic Cancer. Cellular and Molecular Gastroenterology and Hepatology |
| Oni TE, Biffi G, Baker LA, et al. (2020) SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. The Journal of Experimental Medicine. 217 |